Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 88

Similar articles for PubMed (Select 21241969)

1.

Combination stem cell therapy for the treatment of medically refractory coronary ischemia: a Phase I study.

Lasala GP, Silva JA, Kusnick BA, Minguell JJ.

Cardiovasc Revasc Med. 2011 Jan-Feb;12(1):29-34. doi: 10.1016/j.carrev.2010.01.001. Epub 2010 Oct 20.

PMID:
21241969
2.

A novel approach to transplanting bone marrow stem cells to repair human myocardial infarction: delivery via a noninfarct-relative artery.

Yang Z, Zhang F, Ma W, Chen B, Zhou F, Xu Z, Zhang Y, Zhang D, Zhu T, Wang L, Wang H, Ding Z, Zhang Y.

Cardiovasc Ther. 2010 Dec;28(6):380-5. doi: 10.1111/j.1755-5922.2009.00116.x.

PMID:
20337639
3.

Intramyocardial, autologous CD34+ cell therapy for refractory angina.

Losordo DW, Henry TD, Davidson C, Sup Lee J, Costa MA, Bass T, Mendelsohn F, Fortuin FD, Pepine CJ, Traverse JH, Amrani D, Ewenstein BM, Riedel N, Story K, Barker K, Povsic TJ, Harrington RA, Schatz RA; ACT34-CMI Investigators.

Circ Res. 2011 Aug 5;109(4):428-36. doi: 10.1161/CIRCRESAHA.111.245993. Epub 2011 Jul 7.

4.

Intracoronary stem cell infusion in heart transplant candidates.

Yelda T, Berrin U, Murat S, Aytac O, Sevgi B, Yasemin S, Ayşe M, Deniz S, Yilmaz N.

Tohoku J Exp Med. 2007 Oct;213(2):113-20.

5.

Intracoronary infusion of CD133+ endothelial progenitor cells improves heart function and quality of life in patients with chronic post-infarct heart insufficiency.

Flores-Ramírez R, Uribe-Longoria A, Rangel-Fuentes MM, Gutiérrez-Fajardo P, Salazar-Riojas R, Cervantes-García D, Treviño-Ortiz JH, Benavides-Chereti GJ, Espinosa-Oliveros LP, Limón-Rodríguez RH, Monreal-Puente R, González-Treviño JL, Rojas-Martínez A.

Cardiovasc Revasc Med. 2010 Apr-Jun;11(2):72-8. doi: 10.1016/j.carrev.2009.04.001.

PMID:
20347795
6.

CD34+ autologous human stem cells in treating refractory angina.

Perin EC, Willerson JT.

Circ Res. 2011 Aug 5;109(4):351-2. doi: 10.1161/CIRCRESAHA.111.250696. No abstract available.

7.

Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results.

Beeres SL, Bax JJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, van der Wall EE, Schalij MJ, Atsma DE.

Am Heart J. 2006 Oct;152(4):684.e11-6.

PMID:
16996834
8.

One-year follow-up of transcoronary sinus administration of autologous bone marrow in patients with chronic refractory angina.

Vicario J, Campo C, Piva J, Faccio F, Gerardo L, Becker C, Ortega H, Pierini A, Lofeudo C, Novero R, Baliño NP, Monti A, Benech R, Dallo M, Pfeiffer H.

Cardiovasc Revasc Med. 2005 Jul-Sep;6(3):99-107.

PMID:
16275605
9.

Critical single proximal left arterial descending coronary artery stenosis to mimic chronic myocardial ischemia: a new model induced by minimal invasive technology.

Horstick G, Bierbach B, Abegunewardene N, Both S, Kuhn S, Manefeld D, Reinecke HJ, Vosseler M, Helisch A, Becker D, Lauterbach M, Kempski O, Lehr HA.

J Vasc Res. 2009;46(4):290-8. doi: 10.1159/000181545. Epub 2008 Dec 11.

PMID:
19077390
10.

Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina.

Friis T, Haack-Sørensen M, Mathiasen AB, Ripa RS, Kristoffersen US, Jørgensen E, Hansen L, Bindslev L, Kjær A, Hesse B, Dickmeiss E, Kastrup J.

Scand Cardiovasc J. 2011 Jun;45(3):161-8. doi: 10.3109/14017431.2011.569571. Epub 2011 Apr 12.

PMID:
21486102
11.

Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?

Schinkel AF, Poldermans D, Rizzello V, Vanoverschelde JL, Elhendy A, Boersma E, Roelandt JR, Bax JJ.

J Thorac Cardiovasc Surg. 2004 Feb;127(2):385-90.

PMID:
14762345
12.

Assessment of percutaneous coronary intervention on regional and global left ventricular function in patients with chronic total occlusions.

Ermis C, Boz A, Tholakanahalli V, Yalcinkaya S, Semiz E, Sancaktar O, Benditt DG, Deger N.

Can J Cardiol. 2005 Mar;21(3):275-80.

PMID:
15776117
13.

Cardiac shock wave therapy reduces angina and improves myocardial function in patients with refractory coronary artery disease.

Wang Y, Guo T, Cai HY, Ma TK, Tao SM, Sun S, Chen MQ, Gu Y, Pang JH, Xiao JM, Yang XY, Yang C.

Clin Cardiol. 2010 Nov;33(11):693-9. doi: 10.1002/clc.20811.

PMID:
21089114
14.

Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina.

Briguori C, Reimers B, Sarais C, Napodano M, Pascotto P, Azzarello G, Bregni M, Porcellini A, Vinante O, Zanco P, Peschle C, Condorelli G, Colombo A.

Am Heart J. 2006 Mar;151(3):674-80.

PMID:
16504630
15.

Intracoronary transplantation of autologous bone marrow mesenchymal stem cells for ischemic cardiomyopathy due to isolated chronic occluded left anterior descending artery.

Chen S, Liu Z, Tian N, Zhang J, Yei F, Duan B, Zhu Z, Lin S, Kwan TW.

J Invasive Cardiol. 2006 Nov;18(11):552-6.

PMID:
17090821
16.

Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.

Beeres SL, Bax JJ, Kaandorp TA, Zeppenfeld K, Lamb HJ, Dibbets-Schneider P, Stokkel MP, Fibbe WE, de Roos A, van der Wall EE, Schalij MJ, Atsma DE.

Am J Cardiol. 2006 May 1;97(9):1326-31. Epub 2006 Mar 20.

PMID:
16635605
17.

Intramyocardial angiogenic cell precursor injection for cardiomyopathy.

Arom KV, Ruengsakulrach P, Jotisakulratana V.

Asian Cardiovasc Thorac Ann. 2008 Apr;16(2):143-8.

PMID:
18381874
18.

Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.

Mandegar MH, Yousefnia MA, Roshanali F, Rayatzadeh H, Alaeddini F.

J Thorac Cardiovasc Surg. 2008 Oct;136(4):930-6. doi: 10.1016/j.jtcvs.2007.11.061. Epub 2008 May 12.

PMID:
18954632
19.

Predictors of myocardial contractile recovery after coronary revascularization in patients with prior myocardial infarction.

Abdel-Salam Z, Nammas W.

Cardiovasc Revasc Med. 2010 Jan-Mar;11(1):2-7. doi: 10.1016/j.carrev.2009.01.003.

PMID:
20129355
20.

The impact of the capability of circulating progenitor cell to differentiate on myocardial salvage in patients with primary acute myocardial infarction.

Numaguchi Y, Sone T, Okumura K, Ishii M, Morita Y, Kubota R, Yokouchi K, Imai H, Harada M, Osanai H, Kondo T, Murohara T.

Circulation. 2006 Jul 4;114(1 Suppl):I114-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk